Physician profile
Anil Kumar Parekh
NPI 1154343440
$13,049.05
in general payments reported to CMS, 2019-2025
53 companies · $1,991 in 2025
The $1,991 reported for 2025 was more than what 89% of Psychiatry providers received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,265 · 2020: $1,581 · 2021: $1,583 · 2022: $1,114 · 2023: $2,478 · 2024: $2,036 · 2025: $1,991.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,505.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,505.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $2,818.16 | 2019-2025 | Uzedy, Austedo Xr, Austedo |
| Abbvie INC. | $1,530.56 | 2021-2025 | |
| Neurocrine Biosciences, INC. | $1,062.50 | 2019-2025 | Ingrezza, Ongentys |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $899.15 | 2021-2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $667.15 | 2019-2025 | Rexulti, Nuedexta, Abilify Asimtufii |
| Janssen Pharmaceuticals, INC | $650.62 | 2019-2025 | Invega Sustenna, Invega Trinza |
| Lundbeck LLC | $589.66 | 2019-2025 | Rexulti, Vyepti |
| Axsome Therapeutics, INC. | $485.89 | 2023-2025 | Auvelity, Sunosi |
| Alkermes, INC. | $480.34 | 2019-2025 | Lybalvi, Aristada, Aristada Initio |
| Allergan, INC. | $397.83 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $331.68 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $258.48 | 2019-2024 | |
| Supernus Pharmaceuticals, INC. | $218.72 | 2019-2025 | Qelbree, Qelbree |
| Ucb, INC. | $204.55 | 2019-2024 | Briviact |
| Neurelis, INC. | $199.52 | 2020-2024 | Valtoco |
Show all 53 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anil Parekh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.